The Board will consider and evaluate two main agenda items:
1. A proposal for issuance of equity shares or any eligible securities or a combination thereof through various fundraising methods including:
- Preferential issue on a private placement basis
- Qualified institutional placement
- Rights issue
- Any other permissible mode as considered appropriate
This proposal is subject to regulatory/statutory approvals including approval of the company's members. The Board may also approve ancillary actions required in relation to the fundraising.
2. Approval of the Unaudited Financial Results of the Company for the quarter ended 30th June, 2026, along with the Limited Review Report thereon.
Additionally, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the company's securities has been closed for Designated Persons and their immediate relatives since 1st July, 2026. The trading window will remain closed until the expiry of 48 hours after the declaration of the financial results.
The disclosure was signed by Khyati Mishra, Company Secretary and Compliance Officer (Membership No: 70162) on 13th July, 2026 at 16:26:35.